Breaking News, Promotions & Moves

Galapagos Appoints Founding CEO of Newly Created SpinCo

Dr. Paul Stoffels, Chair and CEO of Galapagos, plans to retire as CEO upon the appointment of a successor in the next 12 months.

Author Image

By: Charlie Sternberg

Associate Editor

Galapagos NV, a global biotechnology company, has appointed the founding CEO of its new subsidiary and announced the search for a new CEO of Galapagos. In line with its planned separation into two independent entities, Henry Gosebruch has been appointed as founding CEO of the Galapagos subsidiary, currently named XYZ SpinCo NV, which will be renamed in the Separation. As previously disclosed, SpinCo will separate from Galapagos’ current operations and initially be funded with approximately...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters